Hepatorenal Syndrome Latest Advances

Hepato-Cardio-Renal Interactions and Transplant Implications.

Journal: Transplantation

Published: June 09, 2026

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Journal: Alimentary pharmacology & therapeutics

Published: May 11, 2026

Early 72-h serum creatinine kinetics predict 90-day mortality in hepatorenal syndrome-associated AKI.

Journal: Renal failure

Published: April 14, 2026

Beyond the Tipping Point: Advances in the Diagnosis and Management of Acute-on-Chronic Liver Failure and End-Stage Liver Disease.

Journal: Diagnostics (Basel, Switzerland)

Published: April 12, 2026

The utility of albumin in cirrhosis: established benefits and unanswered questions.

Journal: Current opinion in gastroenterology

Published: March 30, 2026

Response to Letters to the Editor Regarding 'Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-On-Chronic Liver Failure'.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 18, 2026

Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study.

Journal: Journal of clinical medicine

Published: February 12, 2026

Surgical Risk Following Carpal Tunnel Release in Non-cirrhotic Non-alcoholic Fatty Liver Disease Versus Non-alcoholic Cirrhosis: A Propensity-Matched Analysis.

Journal: Cureus

Published: February 12, 2026

Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome - Complications of circulatory failure in cirrhosis

Journal: Deutsche medizinische Wochenschrift (1946)

Published: February 09, 2026

Machine learning outperforms serum creatinine for early risk stratification of hepatorenal syndrome: a prospective single-center validation.

Journal: Hepatology international

Published: February 09, 2026

Post-TIPS Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Comparative Study.

Journal: Journal of clinical gastroenterology

Published: February 05, 2026

United States Experience With Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results From the HRS Harmony Consortium.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 21, 2026

Hepatorenal Syndrome Latest Advances

Find the Latest Research About Hepatorenal Syndrome

Hepato-Cardio-Renal Interactions and Transplant Implications.

Hepato-Cardio-Renal Interactions and Transplant Implications.

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Early 72-h serum creatinine kinetics predict 90-day mortality in hepatorenal syndrome-associated AKI.

Early 72-h serum creatinine kinetics predict 90-day mortality in hepatorenal syndrome-associated AKI.

Beyond the Tipping Point: Advances in the Diagnosis and Management of Acute-on-Chronic Liver Failure and End-Stage Liver Disease.

Beyond the Tipping Point: Advances in the Diagnosis and Management of Acute-on-Chronic Liver Failure and End-Stage Liver Disease.

The utility of albumin in cirrhosis: established benefits and unanswered questions.

The utility of albumin in cirrhosis: established benefits and unanswered questions.

Response to Letters to the Editor Regarding 'Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-On-Chronic Liver Failure'.

Response to Letters to the Editor Regarding 'Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-On-Chronic Liver Failure'.

Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study.

Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study.

Surgical Risk Following Carpal Tunnel Release in Non-cirrhotic Non-alcoholic Fatty Liver Disease Versus Non-alcoholic Cirrhosis: A Propensity-Matched Analysis.

Surgical Risk Following Carpal Tunnel Release in Non-cirrhotic Non-alcoholic Fatty Liver Disease Versus Non-alcoholic Cirrhosis: A Propensity-Matched Analysis.

Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome - Complications of circulatory failure in cirrhosis

Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome - Complications of circulatory failure in cirrhosis

Machine learning outperforms serum creatinine for early risk stratification of hepatorenal syndrome: a prospective single-center validation.

Machine learning outperforms serum creatinine for early risk stratification of hepatorenal syndrome: a prospective single-center validation.

Post-TIPS Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Comparative Study.

Post-TIPS Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Comparative Study.

United States Experience With Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results From the HRS Harmony Consortium.

United States Experience With Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results From the HRS Harmony Consortium.